Compound Profiles
CJC-1295 with DAC
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..
MOTS-c
Mitochondrial-Derived Peptide | Metabolic Regulator
Inhibits the folate cycle leading to AMPK activation. Under metabolic stress, translocates to nucleus to bind stress-response transcription factors, regulating genes involved in metabolism, insulin sensitivity, and cellular adaptation.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 with DAC with MOTS-c?
Yes, CJC-1295 with DAC and MOTS-c can generally be taken together. CJC-1295 with DAC helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects.
Is CJC-1295 with DAC and MOTS-c safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: insulin disrupting. Monitor accordingly.
What are the interactions between CJC-1295 with DAC and MOTS-c?
CJC-1295 with DAC helps counteract the insulin-disrupting effects of MOTS-c. A smart combination — the insulin sensitizer mitigates metabolic side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time CJC-1295 with DAC and MOTS-c?
CJC-1295 with DAC has a half-life of 6-8 days and MOTS-c has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.